Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel DNA-binding compounds presented by CSIR

Dec. 30, 2009

BSI-201 added to gemcitabine/carboplatin improves survival in metastatic TNBC

Dec. 29, 2009

Thallion to close phase II trial of TLN-4601 for glioblastoma multiforme

Dec. 29, 2009

Bryan Oncor reports results of phase I trial of radiolabeled P-2045 in advanced lung cancer

Dec. 29, 2009

Ipsen discloses preliminary data from phase I trial of BN-83495 in breast cancer

Dec. 29, 2009

Teva and OncoGenex sign license and collaboration agreement for OGX-011

Dec. 29, 2009

Synta initiates phase II study of STA-9090 in metastatic or unresectable GIST

Dec. 28, 2009

Phase I data reported for PD-0332991 plus letrozole in advanced breast cancer

Dec. 28, 2009

Everolimus shows clinical activity in Waldenstrom's macroglobulinemia and myelofibrosis

Dec. 28, 2009

EMEA grants orphan drug designation for pixantrone

Dec. 28, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...